Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Akoustis announces closing of public offering of common stock » 07:17
01/25/23
01/25
07:17
01/25/23
07:17
AKTS

Akoustis

$3.39 /

+0.185 (+5.78%)

Akoustis announced the…

Akoustis announced the closing of its previously announced underwritten public offering of 12,545,454 shares of its common stock at a price to the public of $2.75 per share, which included the exercise in full by the underwriters of their option to purchase 1,636,363 additional shares of Akoustis' common stock. Net proceeds to Akoustis, after deducting the underwriting discount and estimated offering expenses payable by Akoustis, were approximately $32.0 million. Akoustis intends to use the net proceeds from the offering to fund operations and the growth of its business, including capital expenditures, working capital, research and development, the commercialization of its technology, servicing its outstanding debt, potential strategic transactions, and other general corporate purposes. Akoustis management participated in the offering with over $1 million in aggregate investments, including an investment of $900K by Akoustis Founder & CEO, Jeff Shealy. B. Riley Securities acted as the sole book-running manager for the offering, and Craig-Hallum Capital Group and Roth Capital Partners acted as co-managers for the offering.

ShowHide Related Items >><<
AKTS Akoustis
$3.39 /

+0.185 (+5.78%)

AKTS Akoustis
$3.39 /

+0.185 (+5.78%)

01/24/23 B. Riley
B. Riley starts Akoustis with Buy on 'robust' growth outlook
01/24/23 B. Riley
Akoustis initiated with a Buy at B. Riley
11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
AKTS Akoustis
$3.39 /

+0.185 (+5.78%)

  • 20
    Jan
AKTS Akoustis
$3.39 /

+0.185 (+5.78%)

Over a week ago
Initiation
B. Riley starts Akoustis with Buy on 'robust' growth outlook » 07:45
01/24/23
01/24
07:45
01/24/23
07:45
AKTS

Akoustis

$3.20 /

+0.18 (+5.96%)

B. Riley analyst Craig…

B. Riley analyst Craig Ellis initiated coverage of Akoustis Technologies with a Buy rating and $9.25 price target. The analyst believes the company offers one of the semiconductor sector's "most robust" 5G sales growth and gross margin expansion outlooks. Akoustis' single-crystal bulk acoustic wave technology is technically robust with a strong patent portfolio and positioned at the radio frequency market's "growthier high end," the analyst tells investors in a research note. The firm believes signs of mobile volume ramps, continued WiFi growth, and progress to cash flow breakeven are stock catalysts.

ShowHide Related Items >><<
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

01/24/23 B. Riley
Akoustis initiated with a Buy at B. Riley
11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

  • 20
    Jan
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

Initiation
Akoustis initiated with a Buy at B. Riley » 05:24
01/24/23
01/24
05:24
01/24/23
05:24
AKTS

Akoustis

$3.20 /

+0.18 (+5.96%)

B. Riley analyst Craig…

B. Riley analyst Craig Ellis initiated coverage of Akoustis Technologies with a Buy rating and $9.25 price target.

ShowHide Related Items >><<
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

  • 20
    Jan
AKTS Akoustis
$3.20 /

+0.18 (+5.96%)

Syndicate
Akoustis 10.91M share Secondary priced at $2.75 » 00:28
01/20/23
01/20
00:28
01/20/23
00:28
AKTS

Akoustis

$2.94 /

-0.605 (-17.09%)

B. Riley acted as lead…

B. Riley acted as lead book running manager for the offering.

ShowHide Related Items >><<
AKTS Akoustis
$2.94 /

-0.605 (-17.09%)

AKTS Akoustis
$2.94 /

-0.605 (-17.09%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
AKTS Akoustis
$2.94 /

-0.605 (-17.09%)

  • 20
    Jan
AKTS Akoustis
$2.94 /

-0.605 (-17.09%)

On The Fly
Fly Intel: After-Hours Movers » 18:35
01/18/23
01/18
18:35
01/18/23
18:35
KMI

Kinder Morgan

$18.36 /

-0.45 (-2.39%)

, SMCI

Super Micro Computer

$78.81 /

-5.98 (-7.05%)

, AKTS

Akoustis

$3.54 /

-0.11 (-3.01%)

, OLK

Olink

$24.00 /

-0.16 (-0.66%)

, DFS

Discover

$102.26 /

-3.155 (-2.99%)

, AA

Alcoa

$53.43 /

-1.48 (-2.70%)

, FUL

H.B. Fuller

$71.73 /

-1.06 (-1.46%)

, WTFC

Wintrust Financial

$82.82 /

-3.66 (-4.23%)

, MATX

Matson

$63.71 /

+0.105 (+0.17%)

Check out this evening's…

ShowHide Related Items >><<
WTFC Wintrust Financial
$82.82 /

-3.66 (-4.23%)

SMCI Super Micro Computer
$78.81 /

-5.98 (-7.05%)

OLK Olink
$24.00 /

-0.16 (-0.66%)

MATX Matson
$63.71 /

+0.105 (+0.17%)

KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

FUL H.B. Fuller
$71.73 /

-1.06 (-1.46%)

DFS Discover
$102.26 /

-3.155 (-2.99%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AA Alcoa
$53.43 /

-1.48 (-2.70%)

KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

12/08/22 Citi
Kinder Morgan initiated with a Neutral at Citi
10/19/22 Barclays
Kinder Morgan price target lowered to $20 from $21 at Barclays
09/07/22 Goldman Sachs
Kinder Morgan upgraded to Neutral from Sell at Goldman Sachs
08/16/22 Barclays
Kinder Morgan price target raised to $21 from $20 at Barclays
SMCI Super Micro Computer
$78.81 /

-5.98 (-7.05%)

01/11/23 Northland
Super Micro short report presents attractive entry point, says Northland
12/29/22 Northland
Super Micro Computer named a top pick entering 2023 at Northland
11/02/22 Northland
Super Micro Computer price target raised to $165 from $137 at Northland
11/02/22 Wedbush
Super Micro Computer price target raised to $65 from $55 at Wedbush
AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
OLK Olink
$24.00 /

-0.16 (-0.66%)

01/05/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
01/04/23 Scotiabank
Olink initiated with an Outperform at Scotiabank
12/14/22 Canaccord
Olink initiated with a Buy at Canaccord
02/16/22 BTIG
Olink price target lowered to $37 from $44 at BTIG
DFS Discover
$102.26 /

-3.155 (-2.99%)

01/06/23 Barclays
Discover downgraded to Equal Weight from Overweight at Barclays
12/15/22 Wells Fargo
Discover price target raised to $115 from $103 at Wells Fargo
12/13/22 BofA
Synchrony downgraded to Neutral at BofA on consumer concerns
12/13/22 BofA
Discover double downgraded to Underperform at BofA on consumer concerns
AA Alcoa
$53.43 /

-1.48 (-2.70%)

12/09/22 Morgan Stanley
Alcoa downgraded to Equal Weight from Overweight at Morgan Stanley
10/21/22 B. Riley
Alcoa price target lowered to $37 from $51 at B. Riley
10/20/22 BMO Capital
Alcoa price target lowered to $35 from $40 at BMO Capital
10/06/22 UBS
Alcoa initiated with a Neutral at UBS
FUL H.B. Fuller
$71.73 /

-1.06 (-1.46%)

10/13/22 Baird
H.B. Fuller margins biased higher despite macro evironment, says Baird
06/24/22 JPMorgan
H.B. Fuller downgraded to Underweight on lack of cash flow at JPMorgan
06/24/22 Deutsche Bank
H.B. Fuller price target lowered to $72 from $85 at Deutsche Bank
06/24/22 JPMorgan
H.B. Fuller downgraded to Underweight from Neutral at JPMorgan
WTFC Wintrust Financial
$82.82 /

-3.66 (-4.23%)

12/09/22 Truist
Wintrust Financial price target lowered to $102 from $112 at Truist
10/20/22 RBC Capital
Wintrust Financial price target raised to $115 from $109 at RBC Capital
10/20/22 Truist
Wintrust Financial price target raised to $112 from $100 at Truist
10/20/22 Raymond James
Wintrust Financial price target raised to $118 from $111 at Raymond James
MATX Matson
$63.71 /

+0.105 (+0.17%)

11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Matson upgraded to Peer Perform from Underperform at Wolfe Research
10/20/22 Stifel
Matson price target lowered to $81 from $93 at Stifel
08/16/22 Wolfe Research
Wolfe starts Matson at Underperform, sees 'peak EPS' in 2022
WTFC Wintrust Financial
$82.82 /

-3.66 (-4.23%)

SMCI Super Micro Computer
$78.81 /

-5.98 (-7.05%)

OLK Olink
$24.00 /

-0.16 (-0.66%)

MATX Matson
$63.71 /

+0.105 (+0.17%)

KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

FUL H.B. Fuller
$71.73 /

-1.06 (-1.46%)

DFS Discover
$102.26 /

-3.155 (-2.99%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AA Alcoa
$53.43 /

-1.48 (-2.70%)

  • 20
    Jan
  • 19
    Jan
  • 08
    Jun
KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

AA Alcoa
$53.43 /

-1.48 (-2.70%)

SMCI Super Micro Computer
$78.81 /

-5.98 (-7.05%)

MATX Matson
$63.71 /

+0.105 (+0.17%)

KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

FUL H.B. Fuller
$71.73 /

-1.06 (-1.46%)

DFS Discover
$102.26 /

-3.155 (-2.99%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AA Alcoa
$53.43 /

-1.48 (-2.70%)

KMI Kinder Morgan
$18.36 /

-0.45 (-2.39%)

DFS Discover
$102.26 /

-3.155 (-2.99%)

AA Alcoa
$53.43 /

-1.48 (-2.70%)

Hot Stocks
Akoustis awarded first high-volume 5G mobile XBAW filter order » 17:01
01/18/23
01/18
17:01
01/18/23
17:01
AKTS

Akoustis

$3.54 /

-0.11 (-3.01%)

The company states:…

The company states: "Akoustis Technologies announced that it has received its first high-volume 5G mobile filter purchase order from its leading multi-billion-dollar Tier-1 RF component company customer. The filter is manufactured using the Akoustis XBAW process and is designed into the customer's new multiplexer product that is expected to ship in the first half of calendar 2023 as part of a major chipset OEM reference design. The filter solution leverages one of Akoustis' new wafer-level-packages, developed and manufactured in its Canandaigua, New York fab. The new XBAW(R)-based design is being used to address difficult coexistence issues between 5G mid-bands and Wi-Fi 6E 5 to 7 GHz bands. The customer is considering additional applications for filters using the XBAW(R) process in future modules for 5G smartphones and other mobile devices after the successful completion of this first solution."

ShowHide Related Items >><<
AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

Syndicate
Akoustis announces common stock offering, no amount given » 16:06
01/18/23
01/18
16:06
01/18/23
16:06
AKTS

Akoustis

$3.54 /

-0.11 (-3.01%)

Akoustis Technologies…

Akoustis Technologies announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Akoustis intends to use the net proceeds from the proposed offering to fund operations and the growth of its business, including for capital expenditures, working capital, research and development, servicing its outstanding debt, potential strategic transactions and for other general corporate purposes. B. Riley Securities is acting as sole book-running manager for the offering. Craig-Hallum Capital Group and ROTH Capital Partners are acting as co-managers.

ShowHide Related Items >><<
AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

AKTS Akoustis
$3.54 /

-0.11 (-3.01%)

Hot Stocks
Akoustis acquires Grinding and Dicing Services for $20M » 07:10
01/04/23
01/04
07:10
01/04/23
07:10
AKTS

Akoustis

$2.80 /

-0.04 (-1.41%)

Akoustis Technologies…

Akoustis Technologies announced that it has acquired Grinding and Dicing Services, a US-based provider of premium back-end semiconductor supply chain services. Akoustis' acquisition of GDSI is expected to support a strategy to reshore its packaging of XBAW filters to the United States and to support its anticipated application for funding under the CHIPS and Science Act. The rationale for the acquisition and expected benefits include: The addition of a diverse, high-margin premium services business that is immediately accretive to our operating model. The gross margins of this new business unit are projected to be approximately 60%; Achievement of $1M in cost savings/avoidance related to RF filter prototype activity within the next 18 months; Strategic alignment with Akoustis' strategy to leverage the CHIPS Act of 2022 to create new jobs as we reshore core packaging capabilities from Asia to an advanced packaging center located on our Canandaigua campus in upstate New York. Specifically, this acquisition allows the opportunity to scale-up our backend core competencies including wafer grinding and Stealth Dicing process capabilities supporting our CSP and WLP onshore package manufacturing; Driving improved rapid prototype and development cycle time for Akoustis XBAW filters through back-end process integration and supply chain efficiencies; Integration of onshore front-end and back-end supply chains supporting national security; New, synergistic sales channels in the defense market, including an active "Trusted Supplier" accreditation with the Department of Defense; The addition of the GDSI management team along with significant technical talent in wafer grinding and dicing to complement Akoustis' front-end XBAW technology; The expansion of XBAW RF filter margins through the internalization of the grinding and dicing process supply chains. Akoustis is paying $14M in cash and $2M in stock for GDSI, with an additional $4M in the form of a secured promissory note payable over 3 years based on key employee retention and agreed upon performance, for a total of $20M. In connection with the transaction, and as an inducement for employment, the company granted to Mr. Collins 242,235 shares of common stock, with an additional 242,235 shares issuable on the second anniversary of the transaction and 121,118 shares issuable on the third anniversary of the transaction, subject to certain employment conditions.

ShowHide Related Items >><<
AKTS Akoustis
$2.80 /

-0.04 (-1.41%)

AKTS Akoustis
$2.80 /

-0.04 (-1.41%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
AKTS Akoustis
$2.80 /

-0.04 (-1.41%)

AKTS Akoustis
$2.80 /

-0.04 (-1.41%)

Over a month ago
On The Fly
What You Missed On Wall Street On Wednesday » 16:32
12/28/22
12/28
16:32
12/28/22
16:32
GNRC

Generac

$96.26 /

+5.11 (+5.61%)

, TSLA

Tesla

$112.71 /

+3.66 (+3.36%)

, RIOT

Riot Blockchain

$3.29 /

-0.135 (-3.95%)

, RIVN

Rivian Automotive

$17.73 /

+0.01 (+0.06%)

, AKLI

Akili

/

+

, IDYA

Ideaya Biosciences

$17.48 /

+0.975 (+5.91%)

, GILD

Gilead

$84.56 /

-0.44 (-0.52%)

, JNCE

Jounce Therapeutics

/

+

, XOM

Exxon Mobil

$108.35 /

-1.8401 (-1.67%)

, AMZN

Amazon.com

$81.85 /

-1.22 (-1.47%)

, DIS

Disney

$84.17 /

-2.21 (-2.56%)

, MMAT

Meta Materials

$1.15 /

+0.161 (+16.36%)

, AKTS

Akoustis

$2.70 /

+0.295 (+12.27%)

, KALA

Kala Pharmaceuticals

$12.47 /

+8.57 (+219.74%)

, TLRY

Tilray

$2.58 /

-0.055 (-2.09%)

, TGTX

TG Therapeutics

$8.46 /

+0.625 (+7.98%)

, MERQ

Merqueo

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

AKLI Akili
/

+

GNRC Generac
$96.26 /

+5.11 (+5.61%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TSLA Tesla
$112.71 /

+3.66 (+3.36%)

12/28/22 Morgan Stanley
Tesla price target lowered to $250 from $330 at Morgan Stanley
12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

12/28/22 Cantor Fitzgerald
Riot, Rivian among Cantor's top technology picks for 2023
12/15/22 Northland
Riot Blockchain price target lowered to $10 from $12 at Northland
12/15/22 DA Davidson
Riot Blockchain price target lowered to $10 from $12 at DA Davidson
11/23/22 H.C. Wainwright
Riot Blockchain assumed with a Buy at H.C. Wainwright
RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

12/20/22 Cantor Fitzgerald
Rivian Automotive initiated with an Overweight at Cantor Fitzgerald
12/20/22 Mizuho
Rivian Automotive price target lowered to $50 from $58 at Mizuho
12/13/22 Canaccord
Rivian Automotive production pause preserves capital, says Canaccord
AKLI Akili
/

+

12/28/22 Morgan Stanley
Akili initiated with an Equal Weight at Morgan Stanley
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA with spending needed to scale
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA
10/25/22 Credit Suisse
Akili Interactive initiated with an Outperform at Credit Suisse
IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

12/28/22 Capital One
Capital One starts Ideaya Biosciences at Overweight with $29 price target
12/28/22 Capital One
Ideaya Biosciences initiated with an Overweight at Capital One
11/18/22 Baird
Ideaya Biosciences price target raised to $24 from $18 at Baird
10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
GILD Gilead
$84.56 /

-0.44 (-0.52%)

12/22/22 Piper Sandler
Gilead's Sunlenca could expand into broader HIV, says Piper Sandler
12/13/22 BofA
Gilead resumed with a Neutral at BofA
12/12/22 Needham
Arcellx price target raised to $35 from $31 at Needham
12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
JNCE Jounce Therapeutics
/

+

11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
11/10/22 Raymond James
Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

12/19/22 Piper Sandler
Exxon Mobil price target lowered to $127 from $131 at Piper Sandler
11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

12/23/22 Citi
Sunday Ticket could accelerate adoption of subscriptions at YouTube, says Citi
12/19/22 Evercore ISI
Amazon.com price target lowered to $150 from $170 at Evercore ISI
12/16/22 JPMorgan
JPMorgan cuts Amazon target, says sentiment at multi-year low
12/12/22 Wells Fargo
Amazon GMV beginning to re-accelerate as softlines comps slow, says Wells Fargo
DIS Disney
$84.17 /

-2.21 (-2.56%)

12/20/22 Wells Fargo
Wells says Disney spinning ESPN/ABC 'a reasonably probable event' for late 2023
12/12/22 Morgan Stanley
Disney price target lowered to $115 from $125 at Morgan Stanley
11/30/22 Atlantic Equities
Atlantic Equities sees 'no easy fix' for Iger at Disney
11/22/22 Tigress Financial
Disney price target lowered to $177 from $229 at Tigress Financial
MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
TLRY Tilray
$2.58 /

-0.055 (-2.09%)

12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

12/29/22 JPMorgan
TG shares under-reflect Briumvi potential, says JPMorgan
12/29/22 H.C. Wainwright
TG Therapeutics price target raised to $24 from $19 at H.C. Wainwright
12/29/22 BofA
BofA sees 'bearish setup' for TG Therapeutics into Briumvi launch
12/28/22 Cantor Fitzgerald
Label for TG Therapeutics' Briumvi slightly better than expected, says Cantor
MERQ Merqueo
/

+

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

AKLI Akili
/

+

  • 15
    Sep
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKLI Akili
/

+

On The Fly
What You Missed On Wall Street This Morning » 12:02
12/28/22
12/28
12:02
12/28/22
12:02
GNRC

Generac

$95.20 /

+4.05 (+4.44%)

, TSLA

Tesla

$110.20 /

+1.15 (+1.05%)

, RIOT

Riot Blockchain

$3.31 /

-0.11 (-3.22%)

, RIVN

Rivian Automotive

$17.63 /

-0.09 (-0.51%)

, AKLI

Akili

$1.04 /

+0.03 (+2.97%)

, IDYA

Ideaya Biosciences

$17.00 /

+0.495 (+3.00%)

, GILD

Gilead

$84.63 /

-0.37 (-0.44%)

, JNCE

Jounce Therapeutics

$1.04 /

+0.3027 (+41.06%)

, XOM

Exxon Mobil

$108.44 /

-1.75 (-1.59%)

, AMZN

Amazon.com

$82.00 /

-1.07 (-1.29%)

, PFE

Pfizer

$50.90 /

-0.22 (-0.43%)

, MMAT

Meta Materials

$1.09 /

+0.101 (+10.26%)

, AKTS

Akoustis

$2.67 /

+0.26 (+10.81%)

, KALA

Kala Pharmaceuticals

$13.20 /

+9.3 (+238.46%)

, TLRY

Tilray

$2.54 /

-0.09 (-3.42%)

, AMC

AMC Entertainment

$3.93 /

-0.12 (-2.96%)

, MERQ

Merqueo

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TSLA Tesla
$110.20 /

+1.15 (+1.05%)

12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
12/22/22 Canaccord
Tesla price target lowered to $275 from $304 at Canaccord
RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

12/28/22 Cantor Fitzgerald
Riot, Rivian among Cantor's top technology picks for 2023
12/15/22 Northland
Riot Blockchain price target lowered to $10 from $12 at Northland
12/15/22 DA Davidson
Riot Blockchain price target lowered to $10 from $12 at DA Davidson
11/23/22 H.C. Wainwright
Riot Blockchain assumed with a Buy at H.C. Wainwright
RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

12/20/22 Cantor Fitzgerald
Rivian Automotive initiated with an Overweight at Cantor Fitzgerald
12/20/22 Mizuho
Rivian Automotive price target lowered to $50 from $58 at Mizuho
12/13/22 Canaccord
Rivian Automotive production pause preserves capital, says Canaccord
AKLI Akili
$1.04 /

+0.03 (+2.97%)

12/28/22 Morgan Stanley
Akili initiated with an Equal Weight at Morgan Stanley
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA with spending needed to scale
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA
10/25/22 Credit Suisse
Akili Interactive initiated with an Outperform at Credit Suisse
IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

12/28/22 Capital One
Capital One starts Ideaya Biosciences at Overweight with $29 price target
12/28/22 Capital One
Ideaya Biosciences initiated with an Overweight at Capital One
11/18/22 Baird
Ideaya Biosciences price target raised to $24 from $18 at Baird
10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
GILD Gilead
$84.63 /

-0.37 (-0.44%)

12/22/22 Piper Sandler
Gilead's Sunlenca could expand into broader HIV, says Piper Sandler
12/13/22 BofA
Gilead resumed with a Neutral at BofA
12/12/22 Needham
Arcellx price target raised to $35 from $31 at Needham
12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
11/10/22 Raymond James
Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

12/19/22 Piper Sandler
Exxon Mobil price target lowered to $127 from $131 at Piper Sandler
11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

12/23/22 Citi
Sunday Ticket could accelerate adoption of subscriptions at YouTube, says Citi
12/19/22 Evercore ISI
Amazon.com price target lowered to $150 from $170 at Evercore ISI
12/16/22 JPMorgan
JPMorgan cuts Amazon target, says sentiment at multi-year low
12/12/22 Wells Fargo
Amazon GMV beginning to re-accelerate as softlines comps slow, says Wells Fargo
PFE Pfizer
$50.90 /

-0.22 (-0.43%)

12/27/22 Cantor Fitzgerald
Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald
12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
12/13/22 Piper Sandler
Takeda deal has positive read through for Ventyx, says Piper
MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
TLRY Tilray
$2.54 /

-0.09 (-3.42%)

12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

11/25/22 Citi
AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
11/06/22 Citi
AMC Entertainment price target lowered to $1.20 from $3.13 at Citi
10/12/22 B. Riley
AMC Entertainment price target lowered to $7.50 from $11 at B. Riley
08/23/22 Wedbush
Wedbush reiterates Underperform rating on AMC Entertainment, cuts target to $2
MERQ Merqueo
/

+

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

  • 15
    Sep
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.